Bone mass status in different degrees of chronic renal failure. 1992

M L Bianchi, and G Colantonio, and A Montesano, and C Trevisan, and S Ortolani, and R Rossi, and G Buccianti
Clinica Medica I, Università di Milano, Italy.

Bone mineral density (BMD) was evaluated in 69 patients with chronic renal failure (CRF) and in healthy controls matched for age, sex, and, for women, menopausal status. Both appendicular (predominantly cortical) and axial (predominantly trabecular) bone mass were measured. Appendicular BMD was measured by single photon absorptiometry on the distal forearm and axial BMD was measured by dual photon absorptiometry on the lumbar spine. Patients were divided into three groups on the basis of creatinine clearance: group 1, 58 to 36 ml/min; group 2, 30 to 18 ml/min; group 3, 15 to 9 ml/min. Both appendicular and axial BMD decreased with the worsening of renal failure. Parathyroid hormone levels were inversely correlated with the values of appendicular BMD. BMD values were significantly lower in postmenopausal than in premenopausal women. Months of menopause were inversely correlated with axial BMD values. Appendicular BMD was lower in CRF patients than in controls, and both appendicular and axial BMD were significantly lower in postmenopausal uremic women than in postmenopausal healthy women.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M L Bianchi, and G Colantonio, and A Montesano, and C Trevisan, and S Ortolani, and R Rossi, and G Buccianti
January 1984, Contributions to nephrology,
M L Bianchi, and G Colantonio, and A Montesano, and C Trevisan, and S Ortolani, and R Rossi, and G Buccianti
September 1980, British medical journal,
M L Bianchi, and G Colantonio, and A Montesano, and C Trevisan, and S Ortolani, and R Rossi, and G Buccianti
January 1991, Terapevticheskii arkhiv,
M L Bianchi, and G Colantonio, and A Montesano, and C Trevisan, and S Ortolani, and R Rossi, and G Buccianti
May 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
M L Bianchi, and G Colantonio, and A Montesano, and C Trevisan, and S Ortolani, and R Rossi, and G Buccianti
July 1975, Clinical nephrology,
M L Bianchi, and G Colantonio, and A Montesano, and C Trevisan, and S Ortolani, and R Rossi, and G Buccianti
June 1976, Nursing times,
M L Bianchi, and G Colantonio, and A Montesano, and C Trevisan, and S Ortolani, and R Rossi, and G Buccianti
June 2004, Nihon rinsho. Japanese journal of clinical medicine,
M L Bianchi, and G Colantonio, and A Montesano, and C Trevisan, and S Ortolani, and R Rossi, and G Buccianti
April 1982, Mineral and electrolyte metabolism,
M L Bianchi, and G Colantonio, and A Montesano, and C Trevisan, and S Ortolani, and R Rossi, and G Buccianti
November 1972, British medical journal,
M L Bianchi, and G Colantonio, and A Montesano, and C Trevisan, and S Ortolani, and R Rossi, and G Buccianti
December 1972, British medical journal,
Copied contents to your clipboard!